Advanz fined by UK CMA over thyroid-drug price hikes
MLex Summary: Pharmaceutical company Advanz and private equity firms HgCapital and Cinven have been fined over 100 million pounds by the UK Competition and Markets Authority for breaching competition law by...To view the full article, register now.
Already a subscriber? Click here to view full article